News & Updates
Filter by Specialty:
Could a single screening colonoscopy prevent CRC?
Results of the NordICC* trial from Europe, presented at the United European Gastroenterology Week (UEG 2022), have hinted at the benefit of a single screening colonoscopy in preventing colorectal cancer (CRC).
Could a single screening colonoscopy prevent CRC?
16 Nov 2022
Elevated blood pressure a red flag for stroke, bleeding in seniors with nonvalvular AF
A systolic blood pressure (BP) of at least 145 mm Hg appears to be a strong predictor of stroke, stroke/systemic embolic events (SEE), major bleeding, and intracranial haemorrhage (ICH) in older patients with nonvalvular atrial fibrillation (AF), according to a study.
Elevated blood pressure a red flag for stroke, bleeding in seniors with nonvalvular AF
16 Nov 2022
Long-term relugolix combo helps with heavy periods, anaemia in women with uterine fibroids
Treatment with relugolix combination for up to 52 weeks yields sustained reductions in heavy menstrual bleeding as well as subsequent increases in iron stores in women with uterine leiomyomas, as shown in a study.
Long-term relugolix combo helps with heavy periods, anaemia in women with uterine fibroids
16 Nov 2022
PTSD may increase risk of cardiovascular diseases
Post-traumatic stress disorder (PTSD) appears to share a genetic risk with cardiovascular disease (CVD), indicating that PTSD is a factor that contributes to the development of coronary artery disease (CAD) and hypertension, reveals a study.
PTSD may increase risk of cardiovascular diseases
16 Nov 2022
Noninvasive scores use LSM to detect cirrhosis, advance fibrosis in NAFLD
Using liver stiffness measurements (LSM) combined with routine clinical parameters, Agile 3+, and Agile 4, both noninvasive scoring methods, can accurately identify advanced fibrosis (AF) and cirrhosis, respectively, in patients with nonalcoholic fatty liver disease (NAFLD), reports a new study.
Noninvasive scores use LSM to detect cirrhosis, advance fibrosis in NAFLD
16 Nov 2022
Adjunctive semaglutide yields additional weight loss in teens with obesity
Once-weekly treatment with semaglutide, when administered with lifestyle intervention, leads to greater reduction in body mass index among adolescents with obesity as compared with lifestyle intervention alone, as shown in the STEP TEENS study.